Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies-Reference-Cited by-同舟云学术

Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies

Published:2023-12 Issue: Volume:195 Page:113399
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Miglietta Federica,Dieci Maria Vittoria^ORCID,Giarratano Tommaso,Torri Valter,Giuliano Mario,Zustovich Fable,Mion Marta^ORCID,Tondini Carlo Alberto,De Rossi Costanza^ORCID,Bria Emilio^ORCID,Franchi Michela,Merlini Laura,Giannatiempo Rosa,Russo Daniela,Fotia Vittoria,Poletti Paola,Caremoli Elena Rota,Arpino Maria Grazia,De Salvo Gian Luca^ORCID,Zambelli Alberto,Guarneri Valentina^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO guideline update;Andre;J Clin Oncol,2022

2. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor–positive breast cancer;Paik;J Clin Oncol,2006

3. Development of the 21-gene assay and its application in clinical practice and clinical trials;Sparano;J Clin Oncol,2008

4. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer;Sparano;N Engl J Med,2018

5. 21-gene assay to inform chemotherapy benefit in node-positive breast cancer;Kalinsky;N Engl J Med,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Excavating regulated cell death signatures to predict prognosis, tumor microenvironment and therapeutic response in HR+/HER2- breast cancer;Translational Oncology;2024-12

2. Multimodal histopathologic models stratify hormone receptor-positive early breast cancer;2024-02-28